Form 4 for WST West Pharmaceutical Services
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001127602-24-007734 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-01 | 2024-02-28 | WST | Witherspoon Charles | VP, Treas | S - Sale+OE | $358.62 | -2,019 | 1,979 | -50% | -$724.1K |
| D | 2024-03-01 | 2024-02-28 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $102.51 | +2,019 | 3,998 | +102% | +$207.0K |
| D | 2024-03-01 | 2024-02-28 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $0.00 | -2,019 | 529 | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | S | D | 2,019 | $358.62 | 1,979.09 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-28 | M | A | 2,019 | $102.51 | 3,998.09 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-02-28 | M | D | 2,019 | $0.00 | 529 | D | $102.51 · 2020-02-19 to 2029-02-19 | 2,019 Stock Options (Right to Buy) | (F1) This award vests in four equal annual installments beginning on February 19, 2020. |